Table 6.
Effect of EASPA on relative organ weights in the subacute toxicity study.
| Group | Liver | Kidneys | Heart | Spleen | Uterus |
|---|---|---|---|---|---|
| Control | 4.63 ± 0.13 | 0.79 ± 0.00 | 0.37 ± 0.01 | 0.25 ± 0.00 | 0.91 ± 0.03 |
| 1.75 mg/kg | 4.49 ± 0.15 | 0.79 ± 0.02 | 0.34 ± 0.01 | 0.24 ± 0.00 | 0.83 ± 0.05 |
| 3.5 mg/kg | 4.53 ± 0.15 | 0.8 ± 0.00 | 0.35 ± 0.01 | 0.23 ± 0.00 | 0.92 ± 0.00 |
| 7 mg/kg | 4.40 ± 0.28 | 0.82 ± 0.02 | 0.34 ± 0.01 | 0.25 ± 0.01 | 0.98 ± 0.00 |
| 14 mg/kg | 3.42 ± 0.29 | 0.73 ± 0.01 | 0.35 ± 0.00 | 0.23 ± 0.00 | 0.82 ± 0.02 |
Values are expressed as a mean ± SEM (n = 6 and p < 0.05).